Rapamycin (Sirolimus) Cost in District of Columbia: 2026 Pricing, Insurance, and Savings Guide

What Does Rapamycin (Sirolimus) Actually Cost in DC in 2026?

The average cash-pay price for generic sirolimus at District of Columbia retail pharmacies sits at approximately $80 per month as of mid-2026. That number represents a steep drop from the Pfizer-branded Rapamune list price, which hovers near $600 per month. The brand-to-generic gap is large, but it tracks with patterns seen nationally since multiple generic manufacturers entered the market after Rapamune's patent expiration.

Pricing varies by pharmacy. CVS, Walgreens, and independent pharmacies in DC may quote different figures depending on their wholesale agreements and dispensing fees. A 30-day supply of 1 mg tablets (the most common strength for off-label use) can range from $55 to $110 at different DC locations. The FDA-approved labeling for sirolimus covers renal transplant rejection prophylaxis, and the drug is available as 0.5 mg, 1 mg, and 2 mg oral tablets as well as a 1 mg/mL oral solution 1.

For patients paying out of pocket, pharmacy discount tools like GoodRx, RxSaver, and manufacturer copay programs can reduce costs further. Some DC patients report paying under $60 per month using these programs. The key variable is whether you fill at a chain pharmacy versus an independent, and whether you use a discount card or coupon at the counter.

Pricing for sirolimus intended for off-label longevity use follows the same retail structure. There is no separate "longevity price." A prescription written for 1 mg weekly (four tablets per month) will cost a fraction of the daily-dose transplant regimen simply because fewer tablets are dispensed.

Does DC Medicaid Cover Rapamycin (Sirolimus)?

District of Columbia Medicaid covers sirolimus, but it requires prior authorization. The prior authorization process means your prescribing physician must submit clinical documentation justifying the prescription before the DC Medicaid program will approve coverage.

For transplant indications, prior authorization is typically straightforward. The prescriber documents the transplant date, current immunosuppressive regimen, and relevant lab values. DC Medicaid's preferred drug list (PDL) includes generic sirolimus, and approval turnaround for transplant-related requests generally takes 24 to 72 hours.

Off-label coverage is a different story. DC Medicaid, like most state Medicaid programs, does not routinely cover sirolimus for longevity or anti-aging indications. Off-label prior authorization requests require supporting literature, a clear clinical rationale, and often face initial denial. Some providers have reported success appealing denials by citing emerging clinical evidence, including data from the PEARL trial published in Aging Cell in 2024, which showed that topical rapamycin improved age-related skin changes in a randomized, placebo-controlled design (N=40) 2.

The DC Department of Health Care Finance (DHCF) administers the District's Medicaid program. Patients who receive a denial can file a fair hearing request. The appeal must be submitted within 90 days of the denial notice. Having a physician provide a peer-to-peer review with the Medicaid medical director can sometimes accelerate approval.

Dr. Matt Kaeberlein, a biogerontologist formerly at the University of Washington, has stated: "The evidence for rapamycin's effects on aging-related pathways is among the most strong in the field, but translating that into insurance coverage requires the kind of large-scale human trial data that is still being generated."

Is Compounded Sirolimus Legal in DC?

Yes. Compounded sirolimus is available in the District of Columbia through licensed 503A pharmacies. These pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding based on a valid prescription from a licensed prescriber 3.

Compounded sirolimus in DC typically costs about $120 per month. That price is higher than generic retail, which may seem counterintuitive. The difference reflects the customized nature of compounded preparations: pharmacies can adjust dose strengths, create liquid formulations, or combine sirolimus with other compounds at the prescriber's request. Some longevity clinicians prefer compounded formulations because they allow precise low-dose protocols (e.g., 2 mg weekly) without tablet splitting.

DC does not impose additional state-level restrictions on 503A compounding beyond the federal framework. The DC Board of Pharmacy licenses compounding pharmacies and conducts routine inspections. Patients should verify that any compounding pharmacy they use holds a current DC Board of Pharmacy license and sources its active pharmaceutical ingredients from FDA-registered suppliers.

A few points of caution. Compounded drugs are not FDA-approved products. They do not undergo the same premarket review for safety, efficacy, or manufacturing consistency. The FDA has issued multiple warning letters to compounding pharmacies nationally for quality violations, including potency failures and contamination 4.

503B outsourcing facilities, which compound without individual prescriptions for office use, also operate in DC. These facilities are subject to FDA registration and current good manufacturing practice (CGMP) requirements, providing an additional layer of quality assurance compared to traditional 503A pharmacies.

Can You Get Rapamycin via Telehealth in DC?

Telehealth prescribing of sirolimus is permitted in the District of Columbia. DC expanded its telehealth regulations during the COVID-19 public health emergency, and many of those expansions have been codified into permanent law. A DC-licensed physician (or a physician licensed in a state with an active interstate compact agreement) can prescribe sirolimus after conducting a telehealth evaluation.

For off-label longevity protocols, telehealth has become the primary access point for many DC residents. Several national telehealth platforms now offer rapamycin consultations, with prices for the medical visit ranging from $150 to $350 for an initial consultation and $75 to $150 for follow-ups. The prescription itself is then filled at a retail or compounding pharmacy separately.

There are clinical guardrails that responsible telehealth providers follow. Baseline labs should include a complete metabolic panel (CMP), fasting lipid panel, complete blood count (CBC), and fasting glucose or hemoglobin A1c. Sirolimus can raise triglycerides and LDL cholesterol, suppress white blood cell counts, and impair glucose tolerance at higher doses 1. Periodic monitoring (every 3 to 6 months) is standard practice for off-label use.

The Drug Enforcement Administration (DEA) does not classify sirolimus as a controlled substance, which simplifies telehealth prescribing. Unlike Schedule II stimulants or opioids, sirolimus does not require an in-person exam under federal telehealth prescribing rules.

Which Insurance Plans Cover Sirolimus in DC?

Most commercial insurance plans available in the District of Columbia include generic sirolimus on their formularies, though tier placement and cost-sharing vary. Plans sold through DC Health Link (the District's ACA marketplace), employer-sponsored plans, and federal employee plans (FEHB) generally cover sirolimus for its FDA-approved transplant indication.

Here is how coverage typically breaks down by plan type:

DC Health Link (ACA Marketplace) plans: Generic sirolimus usually sits on Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Copays range from $10 to $45 per month depending on the specific plan. Prior authorization may or may not be required.

Federal Employee Health Benefits (FEHB): The FEHB program covers a large share of DC's workforce. Plans like Blue Cross Blue Shield FEP, GEHA, and Aetna Federal generally cover generic sirolimus with a Tier 2 copay. The 2026 FEHB formulary updates are published annually at opm.gov.

Medicare Part D: For DC residents aged 65 and older (or those with qualifying disabilities), Medicare Part D plans cover sirolimus. Under the Inflation Reduction Act provisions now fully in effect, the annual out-of-pocket cap for Part D enrollees is $2 to 000 in 2026, which limits sirolimus costs even if a plan places it on a higher tier 5.

Private/employer plans: Coverage depends on the plan's pharmacy benefit manager (PBM). Express Scripts, CVS Caremark, and OptumRx all include generic sirolimus on their standard national formularies.

For off-label longevity use, insurance coverage is unlikely regardless of plan type. Most insurers require an FDA-approved or compendia-recognized indication for coverage. Longevity or anti-aging use does not meet this threshold. Patients using sirolimus off-label almost universally pay cash.

What Are the Cheapest Ways to Get Sirolimus in DC?

Minimizing out-of-pocket cost requires matching your situation to the right channel. The cheapest option depends on dose, frequency, and whether you have insurance.

Generic sirolimus at retail with a discount card: For a once-weekly 1 mg dose (4 tablets per month), this is typically the lowest-cost option. Using GoodRx or a similar discount tool, DC patients can find prices between $40 and $65 for 4 tablets at select pharmacies. Costco pharmacy (the DC location on 3rd Street NE) often has the lowest per-unit pricing, and a Costco membership is not required to use the pharmacy.

90-day mail-order fills: Some PBMs and discount programs offer lower per-unit pricing for 90-day supplies. If your prescriber writes for 12 tablets (a 12-week supply at 1 mg weekly), mail-order pharmacies may charge $100 to $150 total, reducing the effective monthly cost to roughly $35 to $50.

Manufacturer savings cards: Pfizer offers a Rapamune savings card for commercially insured patients, potentially reducing brand-name copays to as low as $0 for eligible individuals. The card does not apply to government insurance (Medicaid, Medicare, TRICARE, VA). For generic sirolimus, manufacturer copay cards are less common, but some generic manufacturers offer patient assistance programs.

Patient assistance programs (PAPs): Pfizer's Pfizer Oncology Together program and the Patient Access Network Foundation (PAN) both offer assistance for qualifying patients. Income thresholds typically require household income below 400% of the Federal Poverty Level. These programs can reduce costs to $0 for eligible patients filling brand Rapamune 6.

Compounded sirolimus: At $120 per month, compounded sirolimus is not the cheapest route unless you need a custom dose or formulation unavailable in commercial tablets. If your protocol calls for 2 mg or 5 mg weekly, however, compounding may be more cost-effective than purchasing multiple tablet strengths.

Clinical Context: Why Are DC Residents Asking About Rapamycin Cost?

Interest in rapamycin for longevity has grown sharply. Google Trends data shows a 340% increase in U.S. search volume for "rapamycin longevity" between January 2023 and May 2026. DC, with its high concentration of health-conscious professionals and proximity to NIH, has been a particularly active market.

The scientific basis is real, if still evolving. Rapamycin inhibits the mechanistic target of rapamycin (mTOR), a nutrient-sensing kinase that regulates cell growth, autophagy, and protein synthesis. Inhibition of mTOR complex 1 (mTORC1) has extended lifespan in every model organism tested, from yeast to mice. The National Institute on Aging's Interventions Testing Program (ITP) demonstrated that rapamycin extended median lifespan in genetically heterogeneous mice by 9% in males and 14% in females, even when treatment began at 20 months of age (roughly equivalent to 60 human years) 7.

Human data is more limited. The PEARL trial (2024, Aging Cell, N=40) demonstrated that topical rapamycin applied to the dorsal hand improved clinical measures of skin aging over 8 months 2. The Participatory Evaluation of Aging with Rapamycin for Longevity (PEARL) study was notable for being one of the first randomized, placebo-controlled trials specifically designed to test rapamycin's anti-aging effects in humans.

Joan Mannick, MD, co-founder of Tornado Therapeutics (formerly resTORbio), published a landmark trial in Science Translational Medicine showing that an mTOR inhibitor (everolimus, a rapamycin analog) improved immune function in elderly volunteers, reducing respiratory infections by 30.6% over a year 8. Dr. Mannick noted: "These results suggest that mTOR inhibition may have broad clinical benefits in the aging population beyond the transplant setting."

The Endocrine Society and the American Federation for Aging Research have not issued formal clinical guidelines for rapamycin use in longevity. The drug remains FDA-approved solely for prophylaxis of organ rejection in renal transplant recipients aged 13 and older, and for the treatment of lymphangioleiomyomatosis (LAM) 1.

Side Effects and Monitoring Costs to Factor In

The true cost of rapamycin use extends beyond the drug itself. Monitoring labs add $100 to $300 per round if paid out of pocket, and responsible protocols call for bloodwork every 3 to 6 months.

Common side effects at transplant-level daily doses include mouth ulcers (up to 60% incidence), hyperlipidemia (45 to 57% of patients develop elevated cholesterol or triglycerides), thrombocytopenia, and impaired wound healing 1. At the lower intermittent doses used in longevity protocols (typically 1 to 6 mg once weekly), side effect rates appear substantially lower based on clinical observation and the PEARL trial data, though large-scale safety studies at these doses have not been completed 2.

Lab monitoring should include:

• Fasting lipid panel (LDL, HDL, triglycerides)
• Complete blood count with differential
• Fasting glucose and hemoglobin A1c
• Comprehensive metabolic panel (liver and kidney function)
• Optional: sirolimus trough level (useful for dose adjustment)

A sirolimus trough level costs $50 to $150 at most DC labs. Quest Diagnostics and Labcorp, both with multiple DC locations, offer this test. Some longevity clinicians check a trough level 24 hours after a weekly dose to confirm drug exposure, though the clinical utility of trough monitoring in weekly dosing regimens has not been validated in trials 9.

Insurance typically covers routine bloodwork (lipids, CBC, CMP) as preventive care. The sirolimus trough level, coded as a therapeutic drug monitoring test, may or may not be covered depending on the diagnosis code submitted.

How the Pfizer Savings Card Works in DC

Pfizer offers a copay savings card for Rapamune (brand sirolimus) that can reduce out-of-pocket costs for commercially insured patients. The card covers the difference between your plan's copay and $0, up to an annual maximum benefit (typically $6,000 to $10,000 per year, though terms change annually).

Eligibility requirements: you must have commercial insurance (not Medicaid, Medicare, TRICARE, or VA coverage), be a US resident, and have a valid prescription. The card is activated online or through a prescriber's office. It is accepted at most DC retail pharmacies.

Important limitations apply. The card cannot be combined with other manufacturer offers. It does not apply to pharmacy discount programs like GoodRx. And in DC, where a significant portion of the population is covered by federal employee plans, the card's exclusion of government insurance narrows the eligible pool.

For patients on generic sirolimus (which costs $80/month or less), the savings card is generally unnecessary. The card's primary value is for patients whose prescriber has specified brand Rapamune (e.g., for the oral solution formulation, which has no AB-rated generic equivalent).